Snowball logo
logo
TEVA_logo

Teva Pharmaceutical Industries Ltd

TEVA β€’ TA
β‚ͺ109.50-β‚ͺ0.70Β  (0.64%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
15,87814,92515,84616,54418,681.317,401.6
COGS
8,2847,9528,2008,4819,049.58,288.3
Gross Profit
7,5946,9737,6468,0639,631.89,128.5
Operating Expenses & Income
Operating Income
1,716(2,099)433(303)4,277.92,977.1
Total Operating Expenses
4,4954,2837,2138,3665,353.96,529.4
R&D Expenses
9678381,0439981,096.51,707
Selling General & Admin Expenses
1,0991,1801,1621,1611,2871,305
Earnings from Continuing Operations
Interest Expense
(1,058)(966)(1,029)(1,002)(1,011)(870)
Interest Income
------
Income Tax Expense
211(638)(7)676(194.8)4.800987
Net Income
Net Income
417(2,353)(559)(1,639)1,527.4724.6
Supplemental
EBIT
1,549(2,233)405(282)2,3362,088.2
EBITDA
2,879(925)1,5587773,420.63,081.9
In millions of ILS, except % and values per 1 share